Company: Pfizer
Tags: culture, layoffs
I survived the Pfizer COVID wind-down restructure and here's what it actually felt like from the inside: chaotic, demoralizing, and then surprisingly okay. The cuts were deep and fast and a lot of good people left. Those of us who stayed found a company that, once the dust settled, was genuinely trying to rebuild intentionally. The Seagen acquisition brought real oncology capability. The culture in my division now is better than before COVID, which I didn't expect to say. I'm not saying Pfizer is perfect. But the narrative that it's just a post-COVID mess isn't accurate from where I sit in 202
13 upvotes · 0 comments